Using Epidemiologic Methods to Advance Comparative Effectiveness Research

Track:
Health Economics and Outcomes (HEO)/Comparative Effectiveness Research (CER)/Health Technology Assessment (HTA)

Day & Time:
June 24, 2:30PM - 4:00PM

Session Number:
140

Room Number:
151B

Level:
Basic

Type:
Session

Title:
Using Epidemiologic Methods to Advance Comparative Effectiveness Research

Chair(s):
Nancy A Dreyer, PhD,MPH,FISPE
Senior Vice President, Global Chief of Scientific Affairs
Quintiles Outcome, United States

Description:
The strengths and limitations of observational studies of comparative effectiveness research will be presented, along with a discussion of epidemiologic methods, resources, and a validated scale for assessing observational study quality.

Learning Objective(s):
Describe the use of knowledge about using epidemiologic methods for comparative effectiveness research; Discuss pros and cons of using observational methods to support comparative effectiveness research; Explain resources available to assist in understanding epidemiologic methods and evaluating studies.

Presentation(s) & Speaker(s):
Science Beyond the Randomized Trial
Kenneth J. Rothman, DrPH,FISPE
Distinguished Fellow
RTI Health Solutions, United States

GRACE Checklist for Observational Studies of Comparative Effectiveness Research
Nancy A Dreyer, PhD,MPH,FISPE
Senior Vice President, Global Chief of Scientific Affairs
Quintiles Outcome, United States

(How) Can Regulators Support CER?
Hans-Georg Eichler, MD,MSc
Senior Medical Officer
European Medicines Agency, European Union, United Kingdom